NCT00537563View on ClinicalTrials.gov

AMS VS MOXI Ketek vs Avelox in AMS

PHASE3CompletedINTERVENTIONAL

Enrollment

351

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Maxillary Sinusitis

Interventions

DRUG

Telithromycin

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00537563 - AMS VS MOXI Ketek vs Avelox in AMS | Biotech Hunter | Biotech Hunter